US Bancorp DE decreased its holdings in Integer Holdings Co. (NYSE:ITGR - Free Report) by 25.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 11,549 shares of the medical equipment provider's stock after selling 3,963 shares during the period. US Bancorp DE's holdings in Integer were worth $1,530,000 as of its most recent SEC filing.
A number of other large investors also recently made changes to their positions in ITGR. Mather Group LLC. grew its stake in shares of Integer by 304.3% in the 4th quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider's stock valued at $25,000 after buying an additional 143 shares in the last quarter. Huntington National Bank grew its stake in shares of Integer by 8,933.3% in the 3rd quarter. Huntington National Bank now owns 271 shares of the medical equipment provider's stock valued at $35,000 after buying an additional 268 shares in the last quarter. R Squared Ltd bought a new stake in shares of Integer in the 4th quarter valued at approximately $44,000. Versant Capital Management Inc grew its stake in shares of Integer by 98.4% in the 4th quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider's stock valued at $49,000 after buying an additional 183 shares in the last quarter. Finally, Principal Securities Inc. grew its stake in shares of Integer by 31.2% in the 4th quarter. Principal Securities Inc. now owns 639 shares of the medical equipment provider's stock valued at $85,000 after buying an additional 152 shares in the last quarter. Institutional investors and hedge funds own 99.29% of the company's stock.
Integer Stock Performance
Shares of ITGR traded down $0.19 during mid-day trading on Tuesday, hitting $120.08. The company's stock had a trading volume of 257,730 shares, compared to its average volume of 304,029. Integer Holdings Co. has a one year low of $107.11 and a one year high of $146.36. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.09 and a current ratio of 2.95. The firm has a market capitalization of $4.04 billion, a PE ratio of 35.74, a price-to-earnings-growth ratio of 1.72 and a beta of 1.24. The stock's 50-day moving average is $134.96 and its two-hundred day moving average is $132.94.
Integer (NYSE:ITGR - Get Free Report) last posted its quarterly earnings data on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share for the quarter, missing the consensus estimate of $1.46 by ($0.03). Integer had a net margin of 6.92% and a return on equity of 11.65%. The business had revenue of $449.50 million during the quarter, compared to the consensus estimate of $446.28 million. As a group, sell-side analysts anticipate that Integer Holdings Co. will post 6.01 EPS for the current year.
Wall Street Analysts Forecast Growth
ITGR has been the subject of several recent research reports. KeyCorp boosted their price target on Integer from $144.00 to $154.00 and gave the company an "overweight" rating in a research note on Friday, January 24th. Wells Fargo & Company reaffirmed an "overweight" rating and set a $160.00 target price on shares of Integer in a research report on Tuesday, December 3rd. Truist Financial upped their target price on Integer from $147.00 to $163.00 and gave the stock a "buy" rating in a research report on Wednesday, December 11th. Citigroup upped their target price on Integer from $130.00 to $145.00 and gave the stock a "neutral" rating in a research report on Wednesday, December 11th. Finally, Oppenheimer cut Integer from an "outperform" rating to a "market perform" rating in a research report on Friday, February 21st. Two research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $147.67.
View Our Latest Stock Analysis on ITGR
Integer Profile
(
Free Report)
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Featured Stories
Before you consider Integer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integer wasn't on the list.
While Integer currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
